Hear from the first patient enrolled in this clinical trial and the immediate impact of this regenerative cell therapy.
View this email in your browser ([link removed])
Logo
** Rescheduled
Stem Cells & Epilepsy: A New Therapeutic Approach for Treating Drug-Resistant Epilepsy
------------------------------------------------------------
[link removed]
Monday, Jan. 30, 2023
2-3 pm CST
Register ([link removed])
This webinar ([link removed]) will discuss a pioneering neural cell therapy approach that could provide a novel treatment for drug-resistant focal epilepsy. Viewers will learn about the promising new data supporting this approach which will be presented by Dr. Robert Beach from the State University of New York (SUNY) Upstate Medical University. They will also hear more about the clinical trial and the immediate impact of this regenerative cell therapy from the first patient enrolled in this clinical trial and a family member.
Register ([link removed])
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed] [link removed] [link removed] [link removed] [link removed] [link removed]
Logo
Copyright (C) 2023 CURE Epilepsy. All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.
Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can update your preferences ([link removed]) or unsubscribe ([link removed])
